Sponsor:
City of Hope Medical Center
Code:
NCT04510051
Conditions
Malignant Brain Neoplasm
Recurrent Malignant Brain Neoplasm
Refractory Malignant Brain Neoplasm
Eligibility Criteria
Sex: All
Age: 4 - 25
Healthy Volunteers: Not accepted
Interventions
Cyclophosphamide
Fludarabine
IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by City of Hope Medical Center on 2025-10-06.